Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Soňa Štruncová is active.

Publication


Featured researches published by Soňa Štruncová.


Nucleic Acids Research | 2009

HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIα

Michal Štros; Eva Polanská; Soňa Štruncová; Šárka Pospíšilová

Topoisomerase IIα (topo IIα) is a nuclear enzyme involved in several critical processes, including chromosome replication, segregation and recombination. Previously we have shown that chromosomal protein HMGB1 interacts with topo IIα, and stimulates its catalytic activity. Here we show the effect of HMGB1 on the activity of the human topo IIα gene promoter in different cell lines. We demonstrate that HMGB1, but not a mutant of HMGB1 incapable of DNA bending, up-regulates the activity of the topo IIα promoter in human cells that lack functional retinoblastoma protein pRb. Transient over-expression of pRb in pRb-negative Saos-2 cells inhibits the ability of HMGB1 to activate the topo IIα promoter. The involvement of HMGB1 and its close relative, HMGB2, in modulation of activity of the topo IIα gene is further supported by knock-down of HMGB1/2, as evidenced by significantly decreased levels of topo IIα mRNA and protein. Our experiments suggest a mechanism of up-regulation of cellular expression of topo IIα by HMGB1/2 in pRb-negative cells by modulation of binding of transcription factor NF-Y to the topo IIα promoter, and the results are discussed in the framework of previously observed pRb-inactivation, and increased levels of HMGB1/2 and topo IIα in tumors.


Transfuze a hematologie dnes | 2008

Průkaz mutace JAK2V617F u pacientů s myeloproliferativnímonemocněním a její význam v klinické praxi

J. Kujíčková; Michael Doubek; Soňa Štruncová; Z. Křístková; Zdeněk Ráčil; Yvona Brychtová; Dana Dvořáková; Jiří Mayer


Annals of Hematology | 2008

Detection and treatment of molecular relapse in acute myeloidleukemia with RUNXa, CBFB, MLL gene translocations, or NPMImutation. Frequent quantitative monitoring of molecular markersin different compartments and correlation with WT1 geneexpression.

Michael Doubek; Ivo Palásek; Zdenek Pospisil; Soňa Štruncová; Dana Dvořáková; Marek Borský; Martin Klabusay; Yvona Brychtová; Marta Krejčí; Jiří Mayer


Archive | 2007

Detekce molekulárního relapsu (MR) akutní myeloidní leukémie(AML) častým a pravidelným sledováním minimální zbytkové nemoci(MRD) prostřednictvím molekulárních markerů v různých buněčnýchpopulacích a léčba molekulárního relapsu

Ivo Palásek; Jiří Mayer; Michael Doubek; Soňa Štruncová; Daniela Žáčková; Yvona Brychtová; Marta Krejčí; Zdeněk Ráčil; Marek Borský; Dana Dvořáková; Jiří Vorlíček


Archive | 2007

Detection fo molecular relapse of AML by very frequentquantitative monitoring of different molecular markers indifferent compartments and its treatment with chemotherapy orgemtuzumab ozogamicin

Ivo Palásek; Michael Doubek; Dana Dvořáková; Yvona Brychtová; Marek Borský; Soňa Štruncová; Marta Krejčí; Jiří Mayer


Archive | 2007

Predikce relapsu akutní myeloidní leukemie po alogennítransplantaci krvetvorných buněk analýzou chimérizmu pomoci PCRv reálném čase

Ondřej Horký; Jiří Mayer; Silvie Bártová; Soňa Štruncová; Marek Borský; Marta Krejčí; Dana Dvořáková


Archive | 2006

Detection of molecular relapse of AML by very frequentquantitative monitoring of different molecular markers (Fusiontranscripts and WTI) in different compartments (peripheralblood, bone marrow, and selected CD34+bone marrow cells) andits treatment...

Jiří Mayer; Ivo Palásek; Zdeněk Pospíšil; Soňa Štruncová; Dana Dvořáková; Marek Borský; Martin Klabusay; Michael Doubek; Yvona Brychtová; Zdeněk Ráčil


Archive | 2005

siRNA silencing of Ewings sarcoma-derived p53 mutants resultsin significant expression changes of neuronal transcriptionfactors.

Šárka Pospíšilová; Boris Tichý; Romana Borská; Soňa Štruncová; Marek Borský; Jana Kotašková; Branislav Kusenda; Heinrich Kovar; Jiří Mayer


Archive | 2005

Gene specific silencing using siRNA in cancer cells.

Soňa Štruncová; Branislav Kusenda; Romana Borská; Boris Tichý; Jana Kotašková; Jiří Mayer; Šárka Pospíšilová


Biologické listy | 2005

RNA interference - účinný nástroj regulace genové exprese

Soňa Štruncová; Romana Borská; Branislav Kusenda; Pavel Mejstřík; Dana Dvořáková; Jiří Mayer; Šárka Pospíšilová

Collaboration


Dive into the Soňa Štruncová's collaboration.

Top Co-Authors

Avatar

Šárka Pospíšilová

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Boris Tichý

Central European Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Doubek

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar

Yvona Brychtová

Charles University in Prague

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jana Kotašková

Central European Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge